mevalonic acid has been researched along with Melanoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosenberg, MW; Krykbaeva, I; Langdon, CG; Means, RE; Micevic, G; Stern, DF; Theodosakis, N | 1 |
| Pich, C; Sarrabayrouse, G; Teiti, I; Tilkin-Mariame, AF | 1 |
| Blegen, H; Carlberg, M; Dricu, A; Hjertman, M; Höög, A; Larsson, O; Wang, M; Zickert, P | 1 |
| Blegen, H; Carlberg, M; Dricu, A; Hjertman, M; Larsson, O; Malec, M; Wang, M; Wejde, J | 1 |
| Carlberg, M; Dricu, A; Griffiths, WJ; Hjertman, M; Larsson, O; Sjövall, J; Wejde, J | 1 |
1 review(s) available for mevalonic acid and Melanoma
| Article | Year |
|---|---|
Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.
Topics: Adaptive Immunity; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Disease Progression; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunity, Innate; Melanoma; Melanoma, Experimental; Mevalonic Acid; Mice; Molecular Targeted Therapy; Neoplasm Proteins; Protein Prenylation; rho GTP-Binding Proteins; Signal Transduction | 2017 |
4 other study(ies) available for mevalonic acid and Melanoma
| Article | Year |
|---|---|
Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancer.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Male; Melanoma; Mevalonic Acid; Mice, Nude; Mitogen-Activated Protein Kinases; Prenylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Signal Transduction | 2019 |
Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth.
Topics: Base Sequence; Cell Division; Cell Line; Cell Membrane; Colonic Neoplasms; DNA Primers; DNA, Neoplasm; Dolichol Phosphates; Enzyme Inhibitors; Gene Expression; Glycosylation; Growth Substances; Hepatoblastoma; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin-Like Growth Factor I; Kinetics; Liver Neoplasms; Lovastatin; Melanoma; Mevalonic Acid; Models, Biological; Molecular Sequence Data; Oligonucleotides, Antisense; Protein Processing, Post-Translational; Receptor, IGF Type 1; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1996 |
Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc.
Topics: Cell Division; Cell Membrane; Colonic Neoplasms; DNA, Neoplasm; Dolichol Phosphates; Glycosylation; Humans; Kinetics; Lovastatin; Melanoma; Mevalonic Acid; Neoplasm Proteins; Polymerase Chain Reaction; Protein Prenylation; ras Proteins; Receptor, IGF Type 1; Skin Neoplasms; Tumor Cells, Cultured | 1997 |
Evidence for protein dolichylation.
Topics: Autoradiography; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cysteine; Dolichols; Hepatoblastoma; Humans; Liver Neoplasms; Melanoma; Mevalonic Acid; Neoplasm Proteins; Peptide Fragments; Protein Prenylation; Sulfur Radioisotopes; Tritium; Tumor Cells, Cultured | 1997 |